Skip to Content

Somatrem use while Breastfeeding

Drugs containing Somatrem: Protropin

Medically reviewed by Drugs.com. Last updated on Feb 9, 2019.

Somatrem Levels and Effects while Breastfeeding

Summary of Use during Lactation

Because somatrem is poorly absorbed orally, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. However, there is no published experience with somatrem during breastfeeding, so an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date. Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date. However, the closely related recombinant human growth hormone, somatropin, has been reported to increase milk production.

Alternate Drugs to Consider

Somatropin

References

Somatrem Identification

Substance Name

Somatrem

CAS Registry Number

82030-87-3

Drug Class

Breast Feeding

Lactation

Human Growth Hormone

Administrative Information

LactMed Record Number

609

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide